Hypoxia Induces High-Mobility-Group Protein I(Y) and Transcription of the Cyclooxygenase-2 Gene in Human Vascular Endothelium

From the Sealy Center for Molecular Cardiology, Department of Medicine, The University of Texas Medical Branch, Galveston, Tex.

Abstract—Cyclooxygenases catalyze a rate-limiting step in the synthesis of vascular endothelial prostaglandins. Expression of the inducible cyclooxygenase-2 (COX-2) gene is increased by hypoxia in human vascular endothelial cells via the nuclear factor (NF)-B p65 transcription factor, which is necessary but not sufficient to fully induce COX-2 transcription in response to hypoxia. After finding that cytoplasmic NF-B p65 and IB (an inhibitory protein that binds NF-B p65 precursors) levels are not changed by hypoxia, we hypothesized that other factors might play a role in regulating the COX-2 promoter, like the high-mobility-group (HMG) I(Y) family of proteins, which features multiple A·T hooks and is associated with NF-B–mediated transactivation. Nuclear protein obtained from human umbilical vein endothelial cells (HUVECs) was supplemented with HMG I(Y) during electrophoretic mobility shift assays using an NF-B-3' element probe. These data suggested that HMG I(Y) proteins interact with NF-B p65 to induce COX-2 promoter activity. We also found that TATA-box DNA demonstrated increased electrophoretic shifting indicative of DNA binding after incubation with either hypoxic HUVEC nuclear protein or normoxic nuclear protein supplemented with HMG I(Y). Transfection of HUVECs with an expression vector containing the COX-2 promoter ligated to HMG I(Y) cDNA demonstrated positive feedback on COX-2 promoter activity in hypoxia. We confirmed that COX-2 is transcriptionally regulated by hypoxia using a nuclear runoff assay. Hypoxia increased steady-state cellular levels of HMG I(Y) mRNA as an early event, corresponding with increases in HMG I(Y) protein. Overexpression of HMG I(Y) was associated in a dose-response relationship with increasing prevalence of the COX-2 protein in hypoxic HUVECs. Furthermore, sense (and antisense) HMG I(Y) overexpression caused stimulation (or inhibition) of COX-2 promoter activity as measured by luciferase reporter gene expression. The physiological significance of these findings was demonstrated by cyclooxygenase-dependent release of prostaglandin E₂ by HUVECs in hypoxia. We concluded that hypoxia increases expression of HMG I(Y) proteins while facilitating transactivation of the COX-2 promoter. The HMG I(Y) family of proteins may therefore function as part of a hypoxia-induced enhanceosome that helps to promote transcription of COX-2.

Key Words: endothelium • hypoxia • HMG I(Y) • cyclooxygenase-2 • prostaglandin E₂

This article has been cited by other articles:

				A. Tesfaye, F. Di Cello, J. Hillion, B. M. Ronnett, O. Elbahloul, R. Ashfaq, S. Dhara, E. Prochownik, K. Tworkoski, R. Reeves, et al. The High-Mobility Group A1 Gene Up-Regulates Cyclooxygenase 2 Expression in Uterine Tumorigenesis Cancer Res., May 1, 2007; 67(9): 3998 - 4004. [Abstract] [Full Text] [PDF]

				R. E. Schweppe, T. H. Cheung, and N. G. Ahn Global Gene Expression Analysis of ERK5 and ERK1/2 Signaling Reveals a Role for HIF-1 in ERK5-mediated Responses J. Biol. Chem., July 28, 2006; 281(30): 20993 - 21003. [Abstract] [Full Text] [PDF]

				I. Csiki, K. Yanagisawa, N. Haruki, S. Nadaf, J. D. Morrow, D. H. Johnson, and D. P. Carbone Thioredoxin-1 Modulates Transcription of Cyclooxygenase-2 via Hypoxia-Inducible Factor-1{alpha} in Non-Small Cell Lung Cancer Cancer Res., January 1, 2006; 66(1): 143 - 150. [Abstract] [Full Text] [PDF]

				C. Y. Cheung Vascular Endothelial Growth Factor Activation of Intramembranous Absorption: A Critical Pathway for Amniotic Fluid Volume Regulation Reproductive Sciences, February 1, 2004; 11(2): 63 - 74. [Abstract] [PDF]

				T. Li, Y.-H. Chen, T.-J. Liu, J. Jia, S. Hampson, Y.-X. Shan, D. Kibler, and P. H. Wang Using DNA Microarray to Identify Sp1 as a Transcriptional Regulatory Element of Insulin-Like Growth Factor 1 in Cardiac Muscle Cells Circ. Res., December 12, 2003; 93(12): 1202 - 1209. [Abstract] [Full Text] [PDF]

				K. Takahashi, Y. Saishin, Y. Saishin, K. Mori, A. Ando, S. Yamamoto, Y. Oshima, H. Nambu, M. B. Melia, D. P. Bingaman, et al. Topical Nepafenac Inhibits Ocular Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 409 - 415. [Abstract] [Full Text] [PDF]

				X. Yang, K. K. K. Sheares, N. Davie, P. D. Upton, G. W. Taylor, J. Horsley, J. Wharton, and N. W. Morrell Hypoxic Induction of Cox-2 Regulates Proliferation of Human Pulmonary Artery Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 688 - 696. [Abstract] [Full Text] [PDF]

				S. T. Davidge Prostaglandin H Synthase and Vascular Function Circ. Res., October 12, 2001; 89(8): 650 - 660. [Abstract] [Full Text] [PDF]

				S. J. Sawyer, S. M. Norvell, S. M. Ponik, and F. M. Pavalko Regulation of PGE2 and PGI2 release from human umbilical vein endothelial cells by actin cytoskeleton Am J Physiol Cell Physiol, September 1, 2001; 281(3): C1038 - C1045. [Abstract] [Full Text] [PDF]

				A. Bonazzi, V. Mastyugin, P. A. Mieyal, M. W. Dunn, and M. Laniado-Schwartzman Regulation of Cyclooxygenase-2 by Hypoxia and Peroxisome Proliferators in the Corneal Epithelium J. Biol. Chem., January 28, 2000; 275(4): 2837 - 2844. [Abstract] [Full Text] [PDF]

				F. Domoki, R. Veltkamp, N. Thrikawala, G. Robins, F. Bari, T. M. Louis, and D. W. Busija Ischemia-reperfusion rapidly increases COX-2 expression in piglet cerebral arteries Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1207 - H1214. [Abstract] [Full Text] [PDF]

				Q. Xu, Y.-S. Ji, and J. F. Schmedtje Jr. Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium. IMPLICATIONS FOR THE MECHANISMS OF AORTIC ANEURYSM AND HEART FAILURE J. Biol. Chem., August 4, 2000; 275(32): 24583 - 24589. [Abstract] [Full Text] [PDF]

				C.-L. M. Cooke and S. T. Davidge Peroxynitrite increases iNOS through NF-kappa B and decreases prostacyclin synthase in endothelial cells Am J Physiol Cell Physiol, February 1, 2002; 282(2): C395 - C402. [Abstract] [Full Text] [PDF]